Literature DB >> 9071844

Combined use of astemizole and ketoconazole resulting in torsade de pointes.

W C Tsai1, L M Tsai, J H Chen.   

Abstract

Torsade de pointes is a serious ventricular arrhythmia which is usually associated with a long QT interval. It is important to recognize the possible predisposing factors for the management of this arrhythmia. Prolongation of the QT interval and torsade de pointes has been reported in patients with an overdose of astemizole. We report on a 63-year-old woman presenting with torsade de pointes and a long QT interval caused by the combined use of astemizole (at recommended dosage), and ketoconazole. After discontinuation of these drugs and treatment with a temporary pacemaker, magnesium sulfate and lidocaine, the arrhythmia was no longer observed and she was discharged in good condition with a normal electrocardiogram. This case should alert clinicians to the possibility of torsade de pointes with the combined use of astemizole and ketoconazole.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9071844

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


  13 in total

Review 1.  Pharmacokinetic factors in the adverse cardiovascular effects of antipsychotic drugs.

Authors:  Candace S Brown; Richard G Farmer; Judith E Soberman; Samantha F Eichner
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

Review 2.  The significance of QT interval in drug development.

Authors:  Rashmi R Shah
Journal:  Br J Clin Pharmacol       Date:  2002-08       Impact factor: 4.335

Review 3.  Drug-induced long QT syndrome.

Authors:  Prince Kannankeril; Dan M Roden; Dawood Darbar
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

Review 4.  Effects of the antifungal agents on oxidative drug metabolism: clinical relevance.

Authors:  K Venkatakrishnan; L L von Moltke; D J Greenblatt
Journal:  Clin Pharmacokinet       Date:  2000-02       Impact factor: 6.447

Review 5.  Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition.

Authors:  G K Dresser; J D Spence; D G Bailey
Journal:  Clin Pharmacokinet       Date:  2000-01       Impact factor: 6.447

Review 6.  Risk factors for drug-induced long-QT syndrome.

Authors:  A D C Paulussen; J Aerssens
Journal:  Neth Heart J       Date:  2005-02       Impact factor: 2.380

7.  Desloratadine has no clinically relevant electrocardiographic or pharmacodynamic interactions with ketoconazole.

Authors:  Christopher Banfield; Jerry Herron; Anther Keung; Desmond Padhi; Melton Affrime
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 8.  Grapefruit juice-drug interactions.

Authors:  D G Bailey; J Malcolm; O Arnold; J D Spence
Journal:  Br J Clin Pharmacol       Date:  1998-08       Impact factor: 4.335

Review 9.  QT prolongation with antimicrobial agents: understanding the significance.

Authors:  Robert C Owens
Journal:  Drugs       Date:  2004       Impact factor: 9.546

10.  Coexistence of hERG current block and disruption of protein trafficking in ketoconazole-induced long QT syndrome.

Authors:  H Takemasa; T Nagatomo; H Abe; K Kawakami; T Igarashi; T Tsurugi; N Kabashima; M Tamura; M Okazaki; B P Delisle; C T January; Y Otsuji
Journal:  Br J Pharmacol       Date:  2007-10-29       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.